This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Partnering with researchers on the ground to reach communities where they are is absolutely critical to making that a reality.” “We Sentinel is more than just a short-lived research program in West Africa,” he said. We learned a lot from Ebola,” Happi said. “We This is how we should be conducting surveillance.
They are often the method of choice to detect or measure specific biological molecules (analytes) for diagnostics, drug discovery or fundamental research. Early beginnings ELISAs were first developed in the mid-1970s independently by two research groups. Many proven applications The use of ELISAs has flourished in the life sciences.
More bottles on the medicine shelf would help, but Bhattacharyya, who’s now also a research scientist, realized that science might lead to better tools for diagnosing and treating such challenging cases. TWO WHITE COATS Roby Bhattacharyya's mother, Maryka, visiting his graduate research lab at UCSF.
His T7 expression technology can be used to make large quantities of nearly any RNA or protein and has been for decades, and continues to be, a mainstay of biomedical research and pharmaceutical production. There’s not a single molecularbiology or biochemistry lab I know that doesn’t use T7.”
In the paper, researchers from Johns Hopkins University and elsewhere found a natural long-form transactivating CRISPR RNA (tracr-L) in Streptococcus pyogenes that functions to downregulate its endogenous CRISPR-Cas9 system.
Several FDA-approved drugs – including for type 2 diabetes, hepatitis C and HIV – significantly reduce the ability of the Delta variant of SARS-CoV-2 to replicate in human cells, according to new research led by scientists at Penn State. 25) in the journal Communications Biology. .
Goodsell, RCSB Protein Data Bank and Scripps Research. Goodsell, RCSB Protein Data Bank and Scripps Research. 1 Yet even after more than two decades of research, media hype, and dozens of clinical trials and biotech start-ups that have come and gone, phage therapy has not scaled. Read it on our website here.
STING is primarily on the lookout for DNA, which can indicate either a foreign invader such as a virus or damage to the host tissue or cell. Now, a team of MIT, Massachusetts General Hospital (MGH), Broad Institute of MIT and Harvard, and Harvard Medical School (HMS) researchers has discovered how STING activates those two pathways.
When Crichton died of cancer in 2008, he left behind a staggering trove of research about an eruption of Mauna Loa on the Big Island of Hawaii. TMV is a common pathogen used in early molecularbiologyresearch. Crichton had an MD from Harvard Medical School, but he never practiced medicine. He was too busy creating.
In a new study published in the journal JCI Insight, Brown University researchers describe the cellular and molecular events that explain why these groups have a higher risk of infection as well as of severe side effects and death. “This paper details a major discovery in COVID-19,” said corresponding author Dr. .”
Highlights of his time at Genome Prairie included increasing the research project portfolio from 3 to 20 concurrent projects, the development of several industry, academia, and government partnerships, as well as the establishment of international consortiums.
Researchers at Karolinska Institutet in Sweden have developed a novel strategy for identifying potent miniature antibodies, so-called nanobodies, against emerging SARS-CoV-2 variants. The approach led to the discovery of multiple nanobodies that in cell cultures and mice effectively blocked infection with different SARS-CoV-2 variants.
Phage have been of interest to scientists as tools to understand fundamental molecularbiology, as vectors of horizontal gene transfer and drivers of bacterial evolution, as sources of diagnostic and genetic tools, and as novel therapeutic agents.
Due to the nearly ubiquitous use of cloning in life science research, this lost time adds up. Researchers use DNA cloning to make numerous copies of a gene, which can then be inserted into living cells to study how that gene functions or otherwise coax the cell to make proteins. However, E.
The researcher at the Max Planck Institute for Developmental Biology received the award in a virtual ceremony for her groundbreaking research on the human microbiome – the totality of all microorganisms that naturally colonize a healthy human – which can reach an impressive mass of approximately one kilogram.
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. 3 Knowing a given population’s seroprevalence is important in understanding how to contain the spread of the virus, as well as how to safely ease lockdown restrictions.
NM: One of the specializations of our research facility in Seattle, WA, is gene therapy. Our biomarker team has a number of cytokine and complement panels designed to detect and quantify these changes in research subjects. Q: How do Your Preclinical and Bioanalytical Teams Work Together to Accelerate Sponsors’ Gene Therapy Research?
In parallel, we are exploring the technical performance of circVec in other viral vectors, as well as non-viral approaches which we expect will surpass virus-based vector-format as the state-of-the-art solutions for gene therapy in the future. So far, we have successfully expressed circRNA from six different vector types.
The researchers measured the fluorescence of each nucleus using a device called a flow cytometer, and found that samples from the New Caledonian fork fern were about 9-times brighter than those from an onion. The HK97 virus, for example, infects E. The New Caledonian fork fern has clearly found a solution to this problem.
While some biologic developers may choose to develop new cell lines in-house, given the extensive resources required to do so, it is common for researchers and/or sponsors to acquire cell seeds from outside laboratories or cell banks. First, viral contaminants may be introduced from starting materials.
The program is being led by Sosei Heptares and progressed in collaboration with multiple companies including Syngene International, Domainex, Fidelta, o2h Discovery, Piramal, WuXi AppTec and the MRC Laboratory of MolecularBiology. References. Hilgenfeld, Febs J. 2014), 281, 4085-4096. Pillaiyar, et al, J. 2016), 59, 6595-6628.
Germany-based Cevec Pharmaceuticals GmbH signed a licensing agreement with Biogen for the use of its proprietary ELEVECTA Technology for the manufacturing of adeno-associated virus (AAV) vectors for gene therapy applications. based Mogrify Limited expanded its research collaboration with MRC Laboratory of MolecularBiology.
For a recent study, researchers edited 21 different genes in poplar trees, a species commonly used to make paper. The researchers studied trees with 70,000 different gene-editing combinations, just 0.5% ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.”
For a recent study, researchers edited 21 different genes in poplar trees, a species commonly used to make paper. The researchers studied trees with 70,000 different gene-editing combinations, just 0.5% ” Wellcome Collection , London I wrapped up my series on “30 Days of Great Biology Papers.”
Goodsell, Scripps Research and RCSB Protein Data Bank. A phage is a virus that infects bacteria. And for another study, researchers engineered bacteriophage T4 to target and deliver payloads to human cells , simply by swapping around the proteins on their outer shells and then coating them in positively-charged lipid molecules.
Goodsell, Scripps Research and RCSB Protein Data Bank. A phage is a virus that infects bacteria. And for another study, researchers engineered bacteriophage T4 to target and deliver payloads to human cells , simply by swapping around the proteins on their outer shells and then coating them in positively-charged lipid molecules.
Base editor proteins were delivered into the mice using a virus, called AAV9. Berg’s work set the stage for the entirety of synthetic biology and genetic engineering. coli genes into a piece of simian virus DNA. I recently asked for recommendations of “classic” papers in molecularbiology.
To survive this era, governments, multi-lateral organisations, foundations, and industry will need to work collectively on researching and developing new drugs that can prevent or treat a broad range of epidemic-prone pathogens, some of which have not yet been identified. All of these factors are being further accelerated by climate change.
Amodei also imagines the ways AI could accelerate biological research and yield miraculous cures in the 21st century; everything from the prevention and treatment of nearly all infectious and inherited diseases to the elimination of most cancers. Still, many of the bottlenecks slowing biology today are biophysical , rather than computational.
From her early fascination with biology to her current role at Regeneron , she has worked on groundbreaking projects aimed at improving the safety, efficacy and durability of gene therapies. Below, she shares insights into her career, impactful research, and the future of genetic medicine.
By Matthew Cobb The Central Dogma is a linchpin for understanding how cells work, and yet it is one of the most widely misunderstood concepts in molecularbiology. Crick was aware of at least four kinds of information transfers, all of which had been observed in biochemical studies by researchers at that time.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content